TauRx global phase 3 trial in Alzheimer's disease with tau aggregation inhibitor LMTX

Claude M. Wischik, C. R. Harrington, J. M. D. Storey

Research output: Contribution to journal › Abstract › peer-review

Fingerprint

Dive into the research topics of 'TauRx global phase 3 trial in Alzheimer's disease with tau aggregation inhibitor LMTX'. Together they form a unique fingerprint.

Medicine & Life Sciences